3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Pituitary Neoplasms
1
Insulinoma
1
Hyperinsulinism
1
Growth Hormone-Secreting Pituitary Adenoma
1
Congenital Hyperinsulinism
1
Acromegaly
1
Interventions
lanreotide
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Temozolomide
1
Surveys and Questionnaires
1
Solutions
1
Radiosurgery
1
Observation
1
Microarray Analysis
1
Injections
1
Early Intervention, Educational
1
Diet, Mediterranean
1
Diet, Ketogenic
1
DNA Methylation
1
Complementary Therapies
1
Biological Therapy
1
90Y-octreotide, DOTA-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Growth Hormone-Secreting Pituitary Adenoma
×
Solutions
×
Endocrine
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled